Clinical trials: Observing the Effectiveness of Targeted HER2 ADC Drugs
Exploring HER2 Positive Diagnostic Criteria in High-grade Serous Ovarian Cancer, Observing the Effectiveness of Targeted HER2 ADC Drugs
Exploratory Study on HER2 Detection Method and Positive Threshold for High-grade Serous Adenocarcinoma of the Ovary
Ovarian cancer is the most lethal gynecological malignancy, and 70% of ovarian cancer patients are diagnosed late at the time of new diagnosis.
- Trial name
- NCT06883487
- Testing
- No intervention
- Where
- China
- Volunteers
- 144 people
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University